Ampio Pharmaceuticals IncOTC Pink - Current Information:AMPE
- LAST PRICE0.4961
- TODAY'S CHANGE (%)0.2541 (104.9876%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.3500 / 0.2420
- Day Range
- 52 Week Range
- Volume7,872
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMPE |
|---|---|---|
| 09:32 ET | 100 | 0.35 |
| 09:36 ET | 4195 | 0.35 |
| 10:32 ET | 200 | 0.4 |
| 10:37 ET | 300 | 0.4 |
| 10:42 ET | 142 | 0.301 |
| 10:50 ET | 500 | 0.4 |
| 11:22 ET | 500 | 0.36 |
| 12:32 ET | 500 | 0.41 |
| 01:28 ET | 401 | 0.51 |
| 01:30 ET | 500 | 0.51 |
| 03:00 ET | 100 | 0.51 |
| 03:48 ET | 283 | 0.49607 |
Apr 3, 2024
Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation, from 2:33PM ET on Wednesday Apr 03, 2024 by Dow Jones
2:33PM ET on Wednesday Apr 03, 2024 by Dow Jones
Mar 25, 2024
DJ Ampio Shares Fall 22% as Co. Plans to Voluntarily Delist From NYSE American, from 5:39PM ET on Monday Mar 25, 2024 by Dow Jones
5:39PM ET on Monday Mar 25, 2024 by Dow JonesAmpio Announces Voluntary Delisting and SEC Deregistration, from 5:00PM ET on Monday Mar 25, 2024 by Dow Jones
5:00PM ET on Monday Mar 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ampio Pharmaceuticals Inc | 563.2K | 0.0x | --- |
Pharmagreen Biotech Inc | 504.4K | -0.7x | --- |
Molecular Pharmacology (USA) Ltd | 599.7K | -0.6x | --- |
Bellerophon Therapeutics Inc | 665.5K | -0.1x | --- |
Allarity Therapeutics Inc | 429.4K | 0.0x | --- |
Life Stem Genetics Inc | 393.3K | -0.1x | --- |
Company Information
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.
Contact Information
- Headquarters
- 9800 Mount Pyramid Court, Suite 400ENGLEWOOD, CO, United States 80112
- Phone
- 720-437-6500
- Fax
- 720-437-6501
Executives
- Independent Chairman of the Board
- J. Kevin Buchi
- Chief Executive Officer, Director
- Michael Martino
- Chief Financial Officer, Secretary
- Daniel Stokely
- Independent Director
- Elizabeth Jobes
- Independent Director
- David Stevens
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $563.2K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 1.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.05 |
EPS | $-11.10 |
Book Value | $4.03 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
